Daxor Corporation's BVA-100 Blood Volume Diagnostic Expands To Three New Centers, Gains Traction Nationwide

Author: Benzinga Newsdesk | July 11, 2024 08:13am

Daxor's ezBVA Lab Service Emerges as Key Driver for Expansion and Market Penetration

Oak Ridge, TN, July 11, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, today announces the expansion of blood volume analysis (BVA). This growth includes launching a BVA program and increasing adoption of Daxor's ezBVA Lab service - a state-of-the-art CLIA certified facility that provides on-demand, next day blood volume analysis results. The company foresees a strong lineup of developments in the second half of this year, reinforcing its trajectory of accelerated sales growth.

Recent sales wins include:

• Regional referral center for Northeast Arkansas and Southeast Missouri starts a BVA program.
• Covenant Health affiliate, a 300-bed facility, integrates Daxor's ezBVA Lab service.
  • Leading South Texas teaching hospital and Level 1 trauma center adopts Daxor's ezBVA Lab service.

Posted In: DXR